hero section gradient
16 handpicked stocks

Apple Onshoring Strategy Explained

Apple's $2.5 billion investment in Corning's U.S. factory marks a significant move to bring iPhone glass production onshore. This theme focuses on the broader trend of reshoring advanced manufacturing, creating opportunities for domestic industrial and technology suppliers.

Author avatar

Han Tan | Market Analyst

Published on September 14

Your Basket's Financial Footprint

Market capitalisation summary and investor takeaways for the provided basket.

Key Takeaways for Investors:
  • Large cap dominance generally implies lower volatility and closer tracking of broad market movements.
  • Suitable as a core, long-term holding rather than a speculative, short-term trade.
  • Likely to deliver steadier, incremental appreciation over time rather than explosive short-term gains.
Total Market Cap
  • MSM: $4.90B

  • PRLB: $1.29B

  • AXL: $715.54M

  • Other

About This Group of Stocks

1

Our Expert Thinking

Apple's massive $2.5 billion investment in Corning's US factory represents a pivotal shift towards onshoring critical manufacturing. This move signals a broader trend where major companies are bringing advanced production back to America to strengthen supply chains and reduce geopolitical risks. We believe this creates lasting opportunities for domestic industrial suppliers.

2

What You Need to Know

This group focuses on companies that provide the essential building blocks for advanced US manufacturing - from factory automation and specialised machinery to industrial materials and logistics support. These businesses operate across the value chain that makes large-scale domestic production possible, positioning them to benefit from similar onshoring investments.

3

Why These Stocks

These companies were handpicked by professional analysts as key enablers of America's industrial base. Each business is positioned to capture demand from the reshoring movement, offering exposure to what could be a durable tailwind as more companies follow Apple's lead in bringing critical production home.

Why You'll Want to Watch These Stocks

🏭

Manufacturing Renaissance

Apple's $2.5 billion bet signals the start of a major shift back to American manufacturing. These companies are perfectly positioned to benefit from this historic onshoring wave.

🚀

First-Mover Advantage

As more tech giants follow Apple's lead in bringing production home, these industrial suppliers could see sustained demand growth for years to come.

🎯

Strategic Supply Chain Play

These aren't just any industrial stocks - they're the essential enablers that make advanced US manufacturing possible, from automation to specialised materials.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Railroad Investment: Beyond the $85 Billion Merger

Railroad Investment: Beyond the $85 Billion Merger

Union Pacific and Norfolk Southern are seeking to merge, creating America's first transcontinental railroad. This landmark consolidation could drive significant investment into rail infrastructure and technology, creating opportunities for companies that support and equip the freight rail industry.

Oracle TikTok Deal May Boost Stocks in 2025

Oracle TikTok Deal May Boost Stocks in 2025

TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.

Pharma Reshoring Explained | Manufacturing Investment

Pharma Reshoring Explained | Manufacturing Investment

Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.

Frequently Asked Questions